These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15352740)

  • 1. Curaçao patients with coronary artery disease have a higher prevalence of the HFE C282Y mutation.
    Dijck-Brouwer DA; Hepkema BG; van der Dijs FP; Steward HN; de Windt-Hol JM; Muskiet FA
    West Indian Med J; 2004 Jun; 53(3):143-6. PubMed ID: 15352740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
    Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemochromatosis gene mutations and risk of coronary artery disease.
    Battiloro E; Ombres D; Pascale E; D'Ambrosio E; Verna R; Arca M
    Eur J Hum Genet; 2000 May; 8(5):389-92. PubMed ID: 10854101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study.
    Rasmussen ML; Folsom AR; Catellier DJ; Tsai MY; Garg U; Eckfeldt JH
    Atherosclerosis; 2001 Feb; 154(3):739-46. PubMed ID: 11257277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
    Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
    Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center.
    Waalen J; Felitti V; Gelbart T; Ho NJ; Beutler E
    Am J Med; 2002 Oct; 113(6):472-9. PubMed ID: 12427496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased C282Y heterozygosity in gestational diabetes.
    Cauza E; Hanusch-Enserer U; Bischof M; Spak M; Kostner K; Tammaa A; Dunky A; Ferenci P
    Fetal Diagn Ther; 2005; 20(5):349-54. PubMed ID: 16113552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of heterozygous hemochromatosis C282Y gene mutation with hand osteoarthritis.
    Ross JM; Kowalchuk RM; Shaulinsky J; Ross L; Ryan D; Phatak PD
    J Rheumatol; 2003 Jan; 30(1):121-5. PubMed ID: 12508400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
    Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemochromatosis (HFE) genotype and atherosclerosis: Increased susceptibility to iron-induced vascular damage in C282Y carriers?
    Engberink MF; Povel CM; Durga J; Swinkels DW; de Kort WL; Schouten EG; Verhoef P; Geleijnse JM
    Atherosclerosis; 2010 Aug; 211(2):520-5. PubMed ID: 20400082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in a Venezuelan sample.
    Vizzi E; Loureiro CL; Gerder M; de las Nieves Garcia-Casal M; Rodríguez-Larralde A; Gerace L; Ludert JE; Liprandi F; Pujol FH
    Ann Hematol; 2005 Nov; 84(12):802-6. PubMed ID: 15995871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes.
    Milman N; Pedersen P; Ovesen L; Melsen GV; Fenger K
    Ann Hematol; 2004 Oct; 83(10):654-7. PubMed ID: 15141324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population.
    Lio D; Balistreri CR; Colonna-Romano G; Motta M; Franceschi C; Malaguarnera M; Candore G; Caruso C
    Genes Immun; 2002 Feb; 3(1):20-4. PubMed ID: 11857056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations in the HFE gene in patients with rheumatic diseases].
    Půtová I; Cimburová M; Jarosová K; Vencovský J; Horák J
    Cas Lek Cesk; 2005; 144(6):391-7; discussion 397-8. PubMed ID: 16047841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands.
    Milman N; á Steig T; Koefoed P; Pedersen P; Fenger K; Nielsen FC
    Ann Hematol; 2005 Mar; 84(3):146-9. PubMed ID: 15042317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
    Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
    Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.